Arcturus Therapeutics ARCT and partner CSL Seqirus, a renowned vaccine company, together reported encouraging results from a ...

CSL and Arcturus Therapeutics report that their sa-mRNA COVID-19 vaccine, ARCT-154, delivered superior immunogenicity ...

A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger ...

Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of ...

According to The People’s Vaccine Alliance, Comirnaty costs an estimated $1.18 per dose to produce. For over two years now, the US government has been running its public vaccination campaign ...

BioNTech is the Marketing Authorization Holder for COMIRNATY ® and its adapted vaccines (COMIRNATY ® (COVID-19 Vaccine, mRNA); COMIRNATY ® Original/Omicron BA.1; COMIRNATY ® Original/Omicron BA.

During the pandemic, Pfizer gave the world the first and most widely used vaccine, Comirnaty, and the oral antiviral pill, Paxlovid. Though in 2021/2022, no company was as strongly placed as ...